Fresenius Medical (FMS) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Hold | $24.00 from $25.00 | Oct 12, 2026 |
| Bernstein | Maintained | Market Perform | $25.80 from $25.50 | Aug 6, 2026 |
| UBS | Downgraded | Neutral → Sell | — | Sep 2, 2025 |
| Truist Securities | Maintained | Hold | $30.00 from $25.00 | May 12, 2025 |
| Truist Securities | Maintained | Hold | $25.00 from $23.00 | Jan 6, 2025 |
| Truist Securities | Maintained | Hold | $23.00 from $22.00 | Oct 7, 2024 |
| Truist Securities | Maintained | Hold | $22.00 from $24.00 | Jul 31, 2024 |
| Truist Securities | Maintained | Hold | $24.00 from $21.00 | May 15, 2024 |
| HSBC | Upgraded | Reduce → Hold | — | Nov 24, 2023 |
| Truist Securities | Maintained | Hold | $24.00 from $28.00 | Oct 11, 2023 |
| Truist Securities | Maintained | Hold | $28.00 from $26.00 | Jul 13, 2023 |
| Truist Securities | Maintained | Hold | $26.00 from $24.00 | May 10, 2023 |
Frequently asked questions
Is FMS a buy, sell, or hold?
Analysts covering Fresenius Medical currently average a Sell rating: 0 buy, 2 hold and 3 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on FMS?
On Oct 12, 2026, Truist Securities maintained Fresenius Medical at Hold with a price target of $24.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.